Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intubation, Intratracheal | 6 | 2002 | 144 | 0.570 |
Why?
|
| Nitrous Oxide | 9 | 1999 | 107 | 0.540 |
Why?
|
| Ear Diseases | 1 | 2015 | 19 | 0.530 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 46 | 0.520 |
Why?
|
| Hematoma | 1 | 2015 | 104 | 0.510 |
Why?
|
| Gastric Dilatation | 1 | 2012 | 3 | 0.430 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 28 | 0.420 |
Why?
|
| Prostatectomy | 1 | 2015 | 471 | 0.420 |
Why?
|
| Robotic Surgical Procedures | 1 | 2015 | 267 | 0.370 |
Why?
|
| Pneumonectomy | 1 | 2012 | 196 | 0.360 |
Why?
|
| Anesthetics, Inhalation | 6 | 2001 | 95 | 0.330 |
Why?
|
| Laparoscopy | 1 | 2015 | 754 | 0.320 |
Why?
|
| Affect | 9 | 2001 | 386 | 0.300 |
Why?
|
| Psychomotor Performance | 12 | 2001 | 492 | 0.290 |
Why?
|
| Anesthesiology | 3 | 1996 | 157 | 0.260 |
Why?
|
| Attitude to Health | 2 | 1996 | 220 | 0.250 |
Why?
|
| Thoracoscopy | 1 | 2004 | 22 | 0.250 |
Why?
|
| Positive-Pressure Respiration | 1 | 2004 | 41 | 0.250 |
Why?
|
| Laryngeal Masks | 2 | 2002 | 12 | 0.250 |
Why?
|
| Methyl Ethers | 3 | 2001 | 33 | 0.250 |
Why?
|
| Palatine Tonsil | 1 | 2002 | 30 | 0.220 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 1999 | 46 | 0.210 |
Why?
|
| Ethers | 2 | 1998 | 14 | 0.200 |
Why?
|
| Anesthesia, General | 2 | 2004 | 114 | 0.190 |
Why?
|
| Pneumonia | 1 | 2002 | 179 | 0.190 |
Why?
|
| Fentanyl | 3 | 1997 | 65 | 0.190 |
Why?
|
| Naloxone | 1 | 1999 | 59 | 0.180 |
Why?
|
| Fiber Optic Technology | 2 | 2000 | 35 | 0.170 |
Why?
|
| Analgesia | 1 | 1999 | 57 | 0.170 |
Why?
|
| Bronchi | 1 | 2000 | 229 | 0.170 |
Why?
|
| Analgesics, Opioid | 3 | 1997 | 413 | 0.160 |
Why?
|
| Lung | 1 | 2004 | 1170 | 0.160 |
Why?
|
| Narcotic Antagonists | 1 | 1999 | 154 | 0.160 |
Why?
|
| Respiration | 2 | 1997 | 262 | 0.160 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1998 | 25 | 0.160 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1997 | 25 | 0.160 |
Why?
|
| Apnea | 1 | 1997 | 29 | 0.150 |
Why?
|
| Bupivacaine | 1 | 1997 | 45 | 0.150 |
Why?
|
| Analgesia, Epidural | 1 | 1997 | 38 | 0.150 |
Why?
|
| Preoperative Care | 2 | 1996 | 397 | 0.150 |
Why?
|
| Esophagogastric Junction | 1 | 1996 | 34 | 0.140 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1997 | 103 | 0.140 |
Why?
|
| Patient Education as Topic | 2 | 1996 | 351 | 0.140 |
Why?
|
| Head-Down Tilt | 1 | 2015 | 5 | 0.140 |
Why?
|
| Ear Canal | 1 | 2015 | 13 | 0.140 |
Why?
|
| Flumazenil | 1 | 1995 | 8 | 0.140 |
Why?
|
| Pulmonary Artery | 1 | 1997 | 306 | 0.140 |
Why?
|
| Carbon Dioxide | 1 | 1996 | 188 | 0.130 |
Why?
|
| Anesthetics | 1 | 1995 | 48 | 0.130 |
Why?
|
| Humans | 32 | 2015 | 86643 | 0.130 |
Why?
|
| Cross-Over Studies | 9 | 1999 | 399 | 0.130 |
Why?
|
| Double-Blind Method | 12 | 2001 | 1823 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 1996 | 319 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 1995 | 151 | 0.130 |
Why?
|
| Physician-Patient Relations | 2 | 1996 | 610 | 0.120 |
Why?
|
| Male | 20 | 2015 | 40965 | 0.120 |
Why?
|
| Pain Measurement | 4 | 1999 | 321 | 0.110 |
Why?
|
| Anesthesia | 3 | 2002 | 164 | 0.110 |
Why?
|
| Aged | 7 | 2015 | 18415 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2002 | 2207 | 0.110 |
Why?
|
| Female | 20 | 2012 | 44532 | 0.100 |
Why?
|
| Respiration, Artificial | 3 | 2004 | 334 | 0.090 |
Why?
|
| Cognition | 5 | 1997 | 570 | 0.090 |
Why?
|
| Rupture | 2 | 2000 | 63 | 0.090 |
Why?
|
| Isoflurane | 2 | 2001 | 64 | 0.080 |
Why?
|
| Adult | 17 | 2002 | 25648 | 0.080 |
Why?
|
| Emergencies | 2 | 1998 | 113 | 0.070 |
Why?
|
| Anesthetics, Intravenous | 2 | 1997 | 41 | 0.070 |
Why?
|
| Administration, Inhalation | 4 | 1999 | 188 | 0.070 |
Why?
|
| Midazolam | 2 | 1996 | 48 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 1721 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 1996 | 455 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2002 | 90 | 0.050 |
Why?
|
| Laryngoscopy | 1 | 2002 | 44 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2002 | 148 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2001 | 69 | 0.050 |
Why?
|
| Amitriptyline | 1 | 2001 | 11 | 0.050 |
Why?
|
| Cold Temperature | 3 | 1996 | 157 | 0.050 |
Why?
|
| Psychomotor Disorders | 2 | 1997 | 20 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 1163 | 0.050 |
Why?
|
| Risk Factors | 3 | 2002 | 5417 | 0.050 |
Why?
|
| Bronchoscopes | 1 | 2000 | 4 | 0.050 |
Why?
|
| Gait | 1 | 2001 | 80 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 106 | 0.050 |
Why?
|
| Trachea | 1 | 2001 | 293 | 0.050 |
Why?
|
| Drug Tolerance | 2 | 1996 | 63 | 0.040 |
Why?
|
| Heart Rate | 2 | 2001 | 492 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2000 | 152 | 0.040 |
Why?
|
| Thiopental | 1 | 1997 | 15 | 0.040 |
Why?
|
| Oxygen | 2 | 1999 | 726 | 0.040 |
Why?
|
| Public Relations | 1 | 1996 | 1 | 0.040 |
Why?
|
| Respiratory Dead Space | 1 | 1996 | 4 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 1997 | 45 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 1996 | 23 | 0.040 |
Why?
|
| Tidal Volume | 1 | 1996 | 53 | 0.040 |
Why?
|
| Australia | 1 | 1996 | 99 | 0.040 |
Why?
|
| Cesarean Section | 1 | 1998 | 137 | 0.040 |
Why?
|
| Butorphanol | 1 | 1996 | 9 | 0.040 |
Why?
|
| United Kingdom | 1 | 1996 | 164 | 0.040 |
Why?
|
| Fear | 1 | 1996 | 78 | 0.040 |
Why?
|
| Analgesics | 1 | 1997 | 119 | 0.040 |
Why?
|
| Awareness | 1 | 1996 | 93 | 0.030 |
Why?
|
| Health Education | 1 | 1996 | 101 | 0.030 |
Why?
|
| Propofol | 1 | 1996 | 89 | 0.030 |
Why?
|
| Droperidol | 1 | 1995 | 3 | 0.030 |
Why?
|
| Personality Inventory | 1 | 1996 | 108 | 0.030 |
Why?
|
| Ketamine | 1 | 1995 | 24 | 0.030 |
Why?
|
| Operating Rooms | 1 | 1996 | 126 | 0.030 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1995 | 36 | 0.030 |
Why?
|
| Euphoria | 1 | 1995 | 43 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 125 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 1997 | 1961 | 0.030 |
Why?
|
| Swine | 1 | 1996 | 555 | 0.030 |
Why?
|
| Leg | 1 | 1995 | 137 | 0.030 |
Why?
|
| Pain Threshold | 1 | 1995 | 58 | 0.030 |
Why?
|
| Physician's Role | 1 | 1996 | 179 | 0.030 |
Why?
|
| Blood Pressure | 2 | 1997 | 1143 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1995 | 107 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 243 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1997 | 267 | 0.030 |
Why?
|
| Heart Arrest | 1 | 1997 | 265 | 0.030 |
Why?
|
| Motivation | 1 | 1996 | 287 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 1995 | 268 | 0.030 |
Why?
|
| Communication | 1 | 1996 | 441 | 0.030 |
Why?
|
| Middle Aged | 3 | 2002 | 25028 | 0.030 |
Why?
|
| Injections, Intravenous | 3 | 1996 | 244 | 0.030 |
Why?
|
| Pregnancy | 1 | 1998 | 2894 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 1987 | 61 | 0.020 |
Why?
|
| Vascular Patency | 1 | 1987 | 126 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1987 | 228 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2001 | 710 | 0.020 |
Why?
|
| United States | 1 | 1996 | 6672 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1996 | 7993 | 0.010 |
Why?
|
| Prospective Studies | 3 | 1996 | 4213 | 0.010 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2001 | 7 | 0.010 |
Why?
|
| Desipramine | 1 | 2001 | 9 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2001 | 136 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2001 | 71 | 0.010 |
Why?
|
| Paroxetine | 1 | 2001 | 26 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2001 | 347 | 0.010 |
Why?
|
| Mental Competency | 1 | 1997 | 49 | 0.010 |
Why?
|
| Animals | 1 | 1996 | 26582 | 0.010 |
Why?
|
| Immersion | 1 | 1996 | 21 | 0.010 |
Why?
|
| Miosis | 1 | 1996 | 10 | 0.010 |
Why?
|
| Codeine | 1 | 1996 | 12 | 0.010 |
Why?
|
| Choice Behavior | 1 | 1997 | 160 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1996 | 248 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 1996 | 136 | 0.010 |
Why?
|
| Acetaminophen | 1 | 1996 | 54 | 0.010 |
Why?
|
| Placebos | 1 | 1996 | 218 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1996 | 153 | 0.010 |
Why?
|
| Memory | 1 | 1997 | 225 | 0.010 |
Why?
|
| Informed Consent | 1 | 1997 | 266 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 1995 | 148 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1996 | 236 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 894 | 0.010 |
Why?
|
| Pain | 1 | 1995 | 391 | 0.010 |
Why?
|
| Sleep | 1 | 1996 | 444 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1987 | 102 | 0.000 |
Why?
|
| Time Factors | 1 | 1996 | 5210 | 0.000 |
Why?
|
| Perfusion | 1 | 1987 | 203 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1987 | 989 | 0.000 |
Why?
|